title: Where and by whom should gastric cancer HER2/neu status be assessed?: lessons from breast cancer.
authors.forename: Manuel
authors.initials: M
authors.lastname: Salto-Tellez
authors.forename: Ee Xuan
authors.initials: EX
authors.lastname: Yau
authors.forename: Benedict
authors.initials: B
authors.lastname: Yan
authors.forename: Stephen B
authors.initials: SB
authors.lastname: Fox
mesh_terms: D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000378:metabolism; D004273:DNA, Neoplasm / Q000032:analysis; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D018734:Genes, erbB-2; D006801:Humans; D007150:Immunohistochemistry; D017404:In Situ Hybridization, Fluorescence; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics / Q000378:metabolism; D013274:Stomach Neoplasms / Q000175:diagnosis* / Q000235:genetics / Q000378:metabolism
chemical_list: D014408:Biomarkers, Tumor; D004273:DNA, Neoplasm; D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human